Vanderbilt Vaccine Center joins effort to stop spread of two deadly viruses
Jim Crowe's chikungunya antibody set to enter clinical trial
VUMC scientists ‘sprint’ to find anti-Zika antibodies
Discovery could lead to neutralizing West Nile virus
Team isolates antibodies that neutralize GI bug norovirus
Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.